Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914062-12-000236
Filing Date
2012-08-29
Accepted
2012-08-29 17:02:44
Documents
1
Period of Report
2012-08-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4097
  Complete submission text file 0000914062-12-000236.txt   5576
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALECTIN THERAPEUTICS, INC. 7 WELLS AVENUE, SUITE 34 NEWTON MA 02459
Business Address
Shlevin Harold H. (Reporting) CIK: 0001557082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 121063860